Can a patient receive albumin during dialysis when the blood urea nitrogen is 74 mg/dL?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Albumin Administration During Dialysis with BUN 74 mg/dL

Yes, a patient can receive albumin during dialysis when their BUN is 74 mg/dL—the BUN level itself is not a contraindication to albumin administration. The decision to use albumin should be based on the specific clinical indication (intradialytic hypotension, hypoalbuminemia, volume status) rather than the BUN value alone.

Clinical Context and Reasoning

The BUN level of 74 mg/dL indicates significant uremia requiring dialysis 1, but this does not preclude albumin use. The key considerations are:

FDA-Approved Indications for Albumin During Dialysis

According to FDA labeling, albumin is indicated in renal dialysis specifically for treatment of shock or hypotension in dialysis patients 2. The typical volume is approximately 100 mL, with particular attention to avoiding fluid overload since these patients often cannot tolerate substantial volumes.

Critical caveat: Albumin is not part of the regular regimen of renal dialysis—it should be reserved for specific complications, not routine use 2.

Evidence-Based Guidance for Intradialytic Use

The 2024 International Collaboration for Transfusion Medicine Guidelines provides important context 3:

  • Limited efficacy data: A Cochrane review found that 5% albumin versus normal saline showed no difference in achieving target ultrafiltration or other clinical outcomes in a small trial (N=45)

  • Some hemodynamic benefit: Small crossover trials suggested that 20% albumin maintained blood pressure better than gelatin or saline, and a 2021 trial (N=65) in hospitalized hemodialysis patients with albumin <30 g/L showed improved hypotension and ultrafiltration rates with 25% albumin versus saline

  • Cost considerations: Annual cost of 25g albumin given thrice-weekly is approximately $20,000 per patient, making it a high-cost intervention without clear superiority over alternatives 3

Recommended Approach

For intradialytic hypotension:

  • First-line strategies: Higher dialysate calcium, lower dialysate temperature, individualized ultrafiltration rates 3
  • Consider midodrine (oral vasopressor) as alternative 3
  • Reserve albumin for refractory hypotension or shock states 2

If albumin is used:

  • Typical dose: 100 mL of 25% albumin 2
  • Monitor closely for fluid overload—these patients have limited capacity to handle volume
  • Consider only if serum albumin <30 g/L based on trial evidence 3

What NOT to Do

Albumin should NOT be used for 2:

  • Chronic nephrosis (rapidly excreted with no benefit)
  • Protein nutrition supplementation in hypoalbuminemia
  • Routine dialysis sessions without specific hemodynamic indication

Bottom Line

The BUN of 74 mg/dL indicates need for dialysis but does not influence the albumin decision. Use albumin only for specific indications (intradialytic hypotension/shock), preferably when serum albumin is low (<30 g/L), and after trying less costly alternatives. The elevated BUN will be addressed by the dialysis itself, not by albumin administration.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.